09.09.2026, 17:46

Promomed launches flagship drug in Kazakhstan

MOSCOW. Sept 9 (Interfax) – Kazakhstan's Health Ministry has granted Promomed a registration certificate for its tirzepatide-based drug, used to treat type 2 diabetes and obesity, the Russian pharmaceutical company said.

To read the full news articles, Subscribe.

02:40PM
Tokayev sets tasks for Security Council staff, flags modern threats

01:06PM
Kazakh PM calls for further fuel market liberalization to spur refining investment

12:30PM
Kyrgyzstan, Kazakhstan, Tajikistan step up border cooperation

11:47AM
Kazakhstan's Kurultai backs European convention to help recover assets stashed abroad

11:42AM
ADB keeps Kazakhstan GDP, inflation forecasts for 2026-2027

11:30AM
Kazakhstan eyes about $6 bln from AIIB over five years

10:49AM
Tokayev appoints Constitutional Court judges, CEC members, Supreme Audit Chamber officials

09:46AM
Russian banks boost corporate lending 1.4% in Aug, consumer loans 1.7% — Central Bank

09:45AM
Russia's grain, oilseed harvest exceeding last year's, important to avoid overstocking - deputy PM

09:45AM
Azerbaijan govt expects revenue from precious metal exports to jump 2.7-fold by 2031

09:44AM
Azerbaijan hoping to stabilize, grow oil production - Aliyev

09:43AM
Azerenerji to build energy storage system for $59 mln

09:37AM
Kazakh foreign minister to present vision for stronger multilateral cooperation at UNGA

09:24AM
Kazakhstan seeks UK expertise, investment for energy projects - Energy Ministry

09:13AM
Two hospitalized with burns after car wash fire in Semey

Press center

https://press.interfax.kz

WE EXPECT A SURGE IN INFLATION IN EARLY 2026 DUE TO TAX REFORM, BUT IT WILL BE ABSORBED BY YEAR-END

KAZAKHSTAN TO ACHIEVE FULL DAIRY SELF-SUFFICIENCY BY 2027, BUT IMPORTS STILL NEEDED

KAZAKHSTAN CAN BECOME A REGIONAL LEADER IN MINERAL EXPLORATION

COUNTRIES TRYING TO BE FRIENDLY WITH EVERYONE CAN BENEFIT AND BECOME MORE ATTRACTIVE FOR INVESTMENT

Promomed launches flagship drug in Kazakhstan

Press center